Pediatrix Medical Group Inc. Shares Cross Above 200-Day Moving Average
PorAinvest
miércoles, 25 de junio de 2025, 4:22 pm ET1 min de lectura
MD--
The company's stock is currently trading at $13.62, with a 52-week range of $6.62 to $17.67. Analysts have assigned an average recommendation of "Hold" to MD, with four equities research analysts rating it as "Hold" and two as "Buy" [2]. The average 1-year target price among brokers is $16.67.
MD's latest quarterly earnings report showed earnings per share (EPS) of $0.33, beating analysts' consensus estimates of $0.25 by $0.08. The company's revenue for the quarter was $458.36 million, down 7.4% year-over-year. The company's return on equity (ROE) was 17.43%, and its net margin was -4.17% [2].
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians [2].
Institutional investors have shown interest in MD, with several hedge funds and other institutional investors owning 97.71% of the company's stock. Vanguard Group Inc., Boston Partners, Geode Capital Management LLC, American Century Companies Inc., and Northern Trust Corp have all increased their holdings in the company in the past quarter [2].
Reference:
[1] https://www.nasdaq.com/articles/md-or-hqy-which-better-value-stock-right-now-2
[2] https://www.marketbeat.com/instant-alerts/pediatrix-medical-group-inc-nysemd-receives-consensus-rating-of-hold-from-analysts-2025-06-24/
NTRS--
Pediatrix Medical Group Inc (MD) shares crossed above their 200-day moving average of $13.62, reaching $13.66 per share, a 1.2% increase. The low point in its 52-week range is $6.62, while the high point is $17.67. The company's stock is currently trading at $13.62.
Pediatrix Medical Group Inc (MD) shares crossed above their 200-day moving average of $13.62, reaching $13.66 per share, a 1.2% increase. This move signifies a potential shift in investor sentiment towards the company, as the 200-day moving average is often used as a key technical indicator.The company's stock is currently trading at $13.62, with a 52-week range of $6.62 to $17.67. Analysts have assigned an average recommendation of "Hold" to MD, with four equities research analysts rating it as "Hold" and two as "Buy" [2]. The average 1-year target price among brokers is $16.67.
MD's latest quarterly earnings report showed earnings per share (EPS) of $0.33, beating analysts' consensus estimates of $0.25 by $0.08. The company's revenue for the quarter was $458.36 million, down 7.4% year-over-year. The company's return on equity (ROE) was 17.43%, and its net margin was -4.17% [2].
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians [2].
Institutional investors have shown interest in MD, with several hedge funds and other institutional investors owning 97.71% of the company's stock. Vanguard Group Inc., Boston Partners, Geode Capital Management LLC, American Century Companies Inc., and Northern Trust Corp have all increased their holdings in the company in the past quarter [2].
Reference:
[1] https://www.nasdaq.com/articles/md-or-hqy-which-better-value-stock-right-now-2
[2] https://www.marketbeat.com/instant-alerts/pediatrix-medical-group-inc-nysemd-receives-consensus-rating-of-hold-from-analysts-2025-06-24/

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios